Arzerra News
Most Popular Arzerra Story
Genmab wins $23M on blockbuster cancer approval
Genmab has won a $23 million milestone payment from GlaxoSmithKline on the FDA's approval of Arzerra (ofatumumab) for chronic lymphocytic leukemia. The FDA provided an accelerated approval of the Read more...
Latest Headlines
- January 22, 2010
- October 27, 2009
- August 18, 2009
- July 30, 2009
- June 16, 2009
- May 21, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
